On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...